Raritan-based Ortho Clinical Diagnostics, a provider of in vitro diagnostics, announced on Tuesday that Joseph M. Busky has been named chief financial officer, effective immediately.
Busky, who has more than 30 years of experience in corporate and operational finance, previously was the CFO at Vyaire Medical Inc. Before that, he was CFO of FDH Velocitel and Innerworkings Inc. He also held a variety of finance-based roles at Siemens Medical Solutions Diagnostics/Dade Behring Holdings Inc., Bayer Diagnostics and Diagnostic Products Corp.
“Joe has a consistent track record driving value creation and enhancing financial models to yield growth and create long-term value,” Chris Smith, CEO, Ortho Clinical Diagnostics, said. “As Ortho Clinical Diagnostics continues to innovate to bring fast, accurate, reliable testing solutions to market, Joe’s extensive experience and strong financial acumen will ensure the company remains poised to deliver these solutions to patients and health care teams globally.”